Here are the top 10 equity deals by dollar amount, according to an Oct. 11 CB Insights report:
1. Dami & Xiaomi (China): $420 million
2. ArsenalBio (U.S.): $220 million
3. Cleerly (U.S.): $192 million
4. Allm (Japan): $182 million
5. Cera (U.K.): $160 million
6. WeDoctor (China): $150 million
7. Alma (U.S.): $130 million
8. Senda Biosciences (U.S.): $123 million
9. Fortanix (U.S.): $90 million
10. Incredible Health (U.S.): $80 million
